ELEVAI LABS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6681 USD | +1.24% |
|
-2.48% | -63.46% |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 31.68 |
| Enterprise Value (EV) 1 | 28.57 |
| P/E ratio | -4.57 x |
| Yield | - |
| Capitalization / Revenue | 18,499,413 x |
| EV / Revenue | 16,679,740 x |
| EV / EBITDA | -7,810,319 x |
| EV / FCF | -12,214,575 x |
| FCF Yield | -0% |
| Price to Book | 8.28 x |
| Nbr of stocks (in thousands) | 17,330 |
| Reference price 2 | 1.828 |
| Announcement Date | 3/29/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales | - | 0.000827 | 0.7663 | 1.713 |
| EBITDA | - | -0.7823 | -1.708 | -3.657 |
| EBIT 1 | -0.2218 | -0.7851 | -1.714 | -3.669 |
| Operating Margin | - | -94,928.9% | -223.72% | -214.24% |
| Earnings before Tax (EBT) 1 | -0.2229 | -0.7847 | -1.8 | -4.302 |
| Net income 1 | -0.2229 | -0.7847 | -1.8 | -4.302 |
| Net margin | - | -94,889.84% | -234.94% | -251.17% |
| EPS 2 | -0.0505 | -0.0829 | -0.1889 | -0.4003 |
| Free Cash Flow | - | -0.4 | -0.8399 | -2.339 |
| FCF margin | - | -48,369.89% | -109.61% | -136.56% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 2/14/23 | 2/14/23 | 9/29/23 | 3/29/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 0.01 | - | - | - |
| Net Cash position 1 | - | 0.41 | 0.87 | 3.12 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | -0.4 | -0.84 | -2.34 |
| ROE (net income / shareholders' equity) | - | -368% | -228% | -174% |
| ROA (Net income/ Total Assets) | - | -144% | -83.8% | -64.8% |
| Assets 1 | - | 0.5464 | 2.149 | 6.642 |
| Book Value Per Share 2 | -0.0100 | 0.0500 | 0.1200 | 0.2200 |
| Cash Flow per Share 2 | 0 | 0.0400 | 0.1200 | 0.1900 |
| Capex | - | 0.03 | 0.04 | 0.01 |
| Capex / Sales | - | 3,927.57% | 4.64% | 0.65% |
| Announcement Date | 2/14/23 | 2/14/23 | 9/29/23 | 3/29/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -63.46% | 11.44M | |
| +67.53% | 62.86B | |
| -0.77% | 41.38B | |
| +45.66% | 40.38B | |
| -10.72% | 27.64B | |
| +13.30% | 26.46B | |
| -22.79% | 18.9B | |
| +4.70% | 12.67B | |
| +24.10% | 12.27B | |
| +27.41% | 12.07B |
- Stock Market
- Equities
- ELAB Stock
- Financials Elevai Labs Inc.
